Previous 10 | Next 10 |
2023-05-10 14:59:05 ET Precigen, Inc. (PGEN) Q1 2023 Earnings Conference Call May 10, 2023 08:00 ET Company Participants Steve Harasym - Vice President, Investor Relations Helen Sabzevari - President & Chief Executive Officer Harry Thomasian - Chief Financial...
2023-05-10 08:08:07 ET Precigen press release ( NASDAQ: PGEN ): Q1 GAAP EPS of -$0.10 in-line. Revenue of $1.85M (-66.4% Y/Y) misses by $1.12M . For further details see: Precigen GAAP EPS of -$0.10 in-line, revenue of $1.85M misses by $1.12M
Precigen Reports First Quarter 2023 Financial Results and Business Updates PR Newswire – Positive Phase 1 clinical data presented for PRGN-2012 AdenoVerse ™ immunotherapy in RRP demonstrated favorable safety profile and significant reduction in s...
2023-05-09 12:10:20 ET Precigen ( NASDAQ: PGEN ) is scheduled to announce Q1 earnings results on Wednesday, May 10th, before market open. The consensus EPS Estimate is -$0.10 (flat Y/Y) and the consensus Revenue Estimate is $2.97M (-90.7% Y/Y). Over the last 3 months, ...
2023-05-04 13:56:05 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Most of the biggest biotech stocks on the market started off as unknown penny stocks . Look at Axsome Therapeutics (NASDAQ: AXSM ), for example. At one time, it was a $2.50 ...
Precigen to Announce First Quarter 2023 Financial Results on May 10th PR Newswire GERMANTOWN, Md. , May 3, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to...
Precigen to Present Latest Clinical Advancements for PRGN-3005 UltraCAR-T® and PRGN-2009 Off-the-Shelf AdenoVerse™ Immunotherapy at the 2023 ASCO Annual Meeting PR Newswire GERMANTOWN, Md. , April 26, 2023 /PRNewswire/ -- Precigen, Inc. ...
2023-04-26 00:15:28 ET Summary After bringing you the first quarter installment covering large-cap and mid-cap insider activity, today's article will focus on the latest insider activity within the small-cap range. We believe that insiders supply the market with high-quality infor...
2023-04-20 14:27:10 ET Putting together a list of penny stocks to watch might seem more complicated if you don’t know how to trade. What are you supposed to look for? Are there certain things that matter more? Do things like insider trading, options stats, volume, etc., matter? I...
2023-04-18 06:40:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many investors look for growth opportunities wherever they can find them. If that describes you, then there are some high-growth biotech stocks that could present an opportunity. ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-03 14:30:04 ET Stifel Nicolaus analyst issues MARKET OUTPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Market Outperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst co...
2024-06-03 14:30:03 ET JMP Securities analyst issues UNDERPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Underperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst consensus : B...
Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response PR Newswire – Phase 1/2 pivotal study met the primary safety and efficacy endpoints ...